Transcription of Saphnelo full Prescribing Information
{{id}} {{{paragraph}}}
Example: dental hygienist
Saphnelo full Prescribing Information
HIGHLIGHTS OF Prescribing Information These highlights do not include all the Information needed to use SAPHNELOTM safely and effectively. See full Prescribing Information for (anifrolumab-fnia) injection, for intravenous useInitial Approval: 2021--------------------------------- INDICATIONS AND USAGE ---------------------------------SAPHNEL O is a type I interferon (IFN) receptor antagonist indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are receiving standard therapy. (1)Limitations of Use: The efficacy of Saphnelo has not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus.
Consider interrupting therapy with SAPHNELO if patients develop a new infection during treatment. (5.1) • Hypersensitivity Reactions Including Anaphylaxis: Serious hypersensitivity reactions including anaphylaxis and angioedema have been reported. (5.2) • Malignancy: Consider the individual benefit-risk in patients with known risk
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: